Back to Atlas
CTransientStandard research/education caution
CMP-0363
Experimental/prohibited risk
ITPP Hexasodium
Ergogenic
Tissue oxygen delivery positioning
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Small molecule
- Primary mechanism
- Hemoglobin oxygen-affinity modulation
- Primary market use
- Performance/ischemia research
Pharmacology
- Molecular weight (Da)
- ~697
- Oral bioavailability
- Oral; limited data
- Half-life
- ~2–12 h small-molecule class estimate
- Route tags
- Route-dependent / verify
- Evidence level
- Preclinical/research
- Clinical status
- Experimental/prohibited risk
- Value-for-money score
- 3 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
EveryChem antioxidant/longevity listing; acute pharmacology